Developing new economic models to incentivise antibiotic discovery and development activities while safeguarding the efficacy of antibiotics by researching and advocating their appropriate use.
New WHO AMR Surveillance and Quality Assessment Collaborating Centres Network Established
In mid-December 2016 the World Health Organization (WHO) established an Antimicrobial Resistance (AMR) Surveillance and Quality Assessment Collaborating...
UK and China to Establish New AMR Research and Innovation Collaboration
Today, during the 2016 UK-China High Level People-to-People Dialogue, the United Kingdom (UK) Secretary of State for Health, Jeremy...
EU Plans to Launch New AMR Action Plan
The European Commission is finalizing a new five-year antimicrobial resistance (AMR) action plan for the region, which will...
DRIVE-AB Partner Otto Cars is SafeCare Person of the Year
DRIVE-AB partner and ReAct Chairman Prof Otto Cars has been named SafeCare Person of the Year by SafeCare magazine....
DRIVE-AB Holds 2nd Annual General Assembly
DRIVE-AB has held its second annual General Assembly Meeting from 17-18 October in Oslo, Norway. The meeting brought...